2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one
C19H20ClN5O3 — CID 171660863
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one
2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one (PubChem CID 171660863) has the molecular formula C19H20ClN5O3 and a molecular weight of 401.85 g/mol. Its IUPAC name is 2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one.
Molecular Properties
| Compound Name | 2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one |
|---|---|
| PubChem CID | 171660863 |
| Molecular Formula | C19H20ClN5O3 |
| Molecular Weight | 401.85 g/mol |
| Exact Mass | 401.13 |
| IUPAC Name | 2-[5-chloro-2-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-pyridinyl]-7-cyclopropyl-5H-pyrazolo[1,5-a]pyrazin-4-one |
| SMILES | O=c1[nH]cc(C2CC2)n2nc(-c3cc(N[C@@H]4CCOC[C@H]4O)ncc3Cl)cc12 |
| InChI | InChI=1S/C19H20ClN5O3/c20-12-7-21-18(23-13-3-4-28-9-17(13)26)5-11(12)14-6-15-19(27)22-8-16(10-1-2-10)25(15)24-14/h5-8,10,13,17,26H,1-4,9H2,(H,21,23)(H,22,27)/t13-,17-/m1/s1 |
| InChIKey | XZYFQNBOGMBMGK-CXAGYDPISA-N |
| XLogP | 2.18 |
| TPSA | 104.54 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 401.85 |
| LogP ≤ 5 | 2.18 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171660863 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.